 Home > Medical News > Latest Medical News > UCB IL-17A/F dual inhibitor starts phase 3 clinical trials in China

UCB IL-17A/F dual inhibitor starts phase 3 clinical trials in China

 Last Update: 2021-05-21
 Source: Internet
 Author: User

Tags

long acyclovir work

long lasting vegetables

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Source: Guanlan Pharmaceutical

The Chinese drug clinical trial registration and information disclosure platform shows that UCB (UCB) has launched a single-arm, international multi-center phase 3 clinical trial of bimekizumab in China for the treatment of active axial spondylitis and ankylosing spine Patients with axial spondyloarthritis with negative inflammation and radiology.

Screenshot source: Chinadrugtrials

Public information shows that bimekizumab is a fully humanized monoclonal antibody that can strongly and specifically neutralize IL-17A and IL-17F.

The launch of Utimes in China is a phase 3, international multi-center, open-ended extension study, which aims to evaluate the treatment of bimekizumab in the treatment of active axial spondylitis, ankylosing spondylitis and radiology-negative axial spine Long-term safety, tolerability and efficacy of arthritis participants.

According to the information on the drug clinical trial registration and information disclosure platform, this is the fourth clinical study of bimekizumab registered in China.

According to a press release issued by Utimer, bimekizumab has obtained positive results in a phase 2b clinical trial for the treatment of ankylosing spondylitis (AS).

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.